Targeting eNOS and beyond: emerging heterogeneity of the role of endothelial Rho proteins in stroke protection

References

• Murphy S, Gibson CL. Nitric oxide, ischaemia and brain inflammation. Biochem. Soc. Trans.35(Pt 5), 1133–1137 (2007).
   PubMed Web of Science ®Google Scholar
• Ginsberg MD. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology55(3), 363–389 (2008).
   PubMed Web of Science ®Google Scholar
• Mehta SL, Manhas N, Raghubir R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res. Rev.54(1), 34–66 (2007).
   PubMed Web of Science ®Google Scholar
• Schlachetzki F, Zhang Y, Boado RJ, Pardridge WM. Gene therapy of the brain: the trans-vascular approach. Neurology62(8), 1275–1281 (2004).
   PubMed Web of Science ®Google Scholar
• Rudic RD, Sessa WC. Nitric oxide in endothelial dysfunction and vascular remodeling: clinical correlates and experimental links. Am. J. Hum. Genet.64(3), 673–677 (1999).
   PubMed Web of Science ®Google Scholar
• Samdani AF, Dawson TM, Dawson VL. Nitric oxide synthase in models of focal ischemia. Stroke28(6), 1283–1288 (1997).
   PubMed Web of Science ®Google Scholar
• Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem. J.298(Pt 2), 249–258 (1994).
   PubMed Web of Science ®Google Scholar
• Murphy S, Simmons ML, Agullo L et al. Synthesis of nitric oxide in CNS glial cells. Trends Neurosci.16(8), 323–328 (1993).
   PubMed Web of Science ®Google Scholar
• Moro MA, Cardenas A, Hurtado O, Leza JC, Lizasoain I. Role of nitric oxide after brain ischaemia. Cell Calcium36(3–4), 265–275 (2004).
   PubMed Web of Science ®Google Scholar
• Malinski T, Bailey F, Zhang ZG, Chopp M. Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion. J. Cereb. Blood Flow Metab.13(3), 355–358 (1993).
   PubMed Web of Science ®Google Scholar
• Huang Z, Huang PL, Panahian N et al. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science265(5180), 1883–1885 (1994).
   PubMed Web of Science ®Google Scholar
• Iadecola C, Zhang F, Casey R, Nagayama M, Ross ME. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J. Neurosci.17(23), 9157–9164 (1997).
   PubMed Web of Science ®Google Scholar
• Endres M, Scott G, Namura S et al. Role of peroxynitrite and neuronal nitric oxide synthase in the activation of poly (ADP-ribose) synthetase in a murine model of cerebral ischemia–reperfusion. Neurosci. Lett.248(1), 41–44 (1998).
   PubMed Web of Science ®Google Scholar
• Koppenol WH, Moreno JJ, Pryor WA, Ischiropoulos H, Beckman JS. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem. Res. Toxicol.5(6), 834–842 (1992).
   PubMed Web of Science ®Google Scholar
• Clementi E, Brown GC, Feelisch M, Moncada S. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc. Natl Acad. Sci. USA95(13), 7631–7636 (1998).
   PubMed Web of Science ®Google Scholar
• Huang Z, Huang PL, Ma J et al. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J. Cereb. Blood Flow Metab.16(5), 981–987 (1996).
   PubMed Web of Science ®Google Scholar
• Lo EH, Hara H, Rogowska J et al. Temporal correlation mapping analysis of the hemodynamic penumbra in mutant mice deficient in endothelial nitric oxide synthase gene expression. Stroke27(8), 1381–1385 (1996).
   PubMed Web of Science ®Google Scholar
• Dalkara T, Morikawa E, Panahian N, Moskowitz MA. Blood flow-dependent functional recovery in a rat model of focal cerebral ischemia. Am. J. Physiol.267(2 Pt 2), H678–H683 (1994).
   PubMedGoogle Scholar
• Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am. J. Physiol. Regul. Integr. Comp. Physiol.284(1), R1–R12 (2003).
   PubMed Web of Science ®Google Scholar
• Fulton D, Gratton JP, Sessa WC. Post-translational control of endothelial nitric oxide synthase: why isn’t calcium/calmodulin enough? J. Pharmacol. Exp. Ther.299(3), 818–824 (2001).
   PubMed Web of Science ®Google Scholar
• Liu VW, Huang PL. Cardiovascular roles of nitric oxide: a review of insights from nitric oxide synthase gene disrupted mice. Cardiovasc. Res.77(1), 19–29 (2008).
   PubMed Web of Science ®Google Scholar
• Dimmeler S, Fleming I, Fisslthaler B et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature399(6736), 601–605 (1999).
   PubMed Web of Science ®Google Scholar
• Fulton D, Gratton JP, McCabe TJ et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature399(6736), 597–601 (1999).
   PubMed Web of Science ®Google Scholar
• Shaul PW. Regulation of endothelial nitric oxide synthase: location, location, location. Annu. Rev. Physiol.64, 749–774 (2002).
   PubMed Web of Science ®Google Scholar
• Reinoso RF, Sanchez Navarro A, Garcia MJ, Prous JR. Preclinical pharmacokinetics of statins. Methods Find Exp. Clin. Pharmacol.24(9), 593–613 (2002).
   PubMed Web of Science ®Google Scholar
• Endres M. Statins and stroke. J. Cereb. Blood Flow Metab.25(9), 1093–1110 (2005).
   PubMed Web of Science ®Google Scholar
• Endres M, Laufs U, Huang Z et al. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc. Natl Acad. Sci. USA95(15), 8880–8885 (1998).
   PubMed Web of Science ®Google Scholar
• Yamada M, Huang Z, Dalkara T et al. Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment. J. Cereb. Blood Flow Metab.20(4), 709–717 (2000).
   PubMed Web of Science ®Google Scholar
• Sironi L, Cimino M, Guerrini U et al. Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage. Arterioscler. Thromb. Vasc. Biol.23(2), 322–327 (2003).
   PubMed Web of Science ®Google Scholar
• Kawashima S, Yamashita T, Miwa Y et al. HMG-CoA reductase inhibitor has protective effects against stroke events in stroke-prone spontaneously hypertensive rats. Stroke34(1), 157–163 (2003).
   PubMed Web of Science ®Google Scholar
• Laufs U. Beyond lipid-lowering: effects of statins on endothelial nitric oxide. Eur J. Clin. Pharmacol.58(11), 719–731 (2003).
   PubMed Web of Science ®Google Scholar
• Hernandez-Perera O, Perez-Sala D, Navarro-Antolin J et al. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J. Clin. Invest.101(12), 2711–2719 (1998).
   PubMed Web of Science ®Google Scholar
• Laufs U, Liao JK. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J. Biol. Chem.273(37), 24266–24271 (1998).
   PubMed Web of Science ®Google Scholar
• Laufs U, Endres M, Stagliano N et al. Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J. Clin. Invest.106(1), 15–24 (2000).
   PubMed Web of Science ®Google Scholar
• Rikitake Y, Kim HH, Huang Z et al. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke36(10), 2251–2257 (2005).
   PubMed Web of Science ®Google Scholar
• Dimmeler S, Aicher A, Vasa M et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J. Clin. Invest.108(3), 391–397 (2001).
   PubMed Web of Science ®Google Scholar
• Kureishi Y, Luo Z, Shiojima I et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat. Med.6(9), 1004–1010 (2000).
   PubMed Web of Science ®Google Scholar
• Wolfrum S, Dendorfer A, Rikitake Y et al. Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler. Thromb. Vasc. Biol.24(10), 1842–1847 (2004).
   PubMed Web of Science ®Google Scholar
• Shin HK, Salomone S, Potts EM et al. Rho-kinase inhibition acutely augments blood flow in focal cerebral ischemia via endothelial mechanisms. J. Cereb. Blood Flow Metab.27(5), 998–1009 (2007).
   PubMed Web of Science ®Google Scholar
• Atochin DN, Wang A, Liu VW et al. The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. J. Clin. Invest.117(7), 1961–1967 (2007).
   PubMedGoogle Scholar
• Asahi M, Huang Z, Thomas S et al. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. J. Cereb. Blood Flow Metab.25(6), 722–729 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang ZG, Ding GL et al. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat. Circulation112(22), 3486–3494 (2005).
   PubMed Web of Science ®Google Scholar
• Mayanagi K, Katakam PV, Gaspar T, Domoki F, Busija DW. Acute treatment with rosuvastatin protects insulin resistant (C57BL/6J ob/ob) mice against transient cerebral ischemia. J. Cereb. Blood Flow Metab.28(12), 1927–1935 (2008).
   PubMed Web of Science ®Google Scholar
• Taylor WC, Landau WM. Atherosclerosis and stroke. Ann. Neurol.28(1), 108–109 (1990).
   PubMedGoogle Scholar
• Atkins D, Psaty BM, Koepsell TD, Longstreth WT Jr, Larson EB. Cholesterol reduction and the risk for stroke in men. A meta-analysis of randomized, controlled trials. Ann. Intern. Med.119(2), 136–145 (1993).
   PubMed Web of Science ®Google Scholar
• Hebert PR, Gaziano JM, Chan KS, Hennekens CH. Cholesterol lowering with statin drugs, risk of stroke, and total mortality: an overview of randomized trials. JAMA278(4), 313–321 (1997).
   PubMed Web of Science ®Google Scholar
• Iso H, Jacobs DR Jr, Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N. Engl. J. Med.320(14), 904–910 (1989).
   PubMed Web of Science ®Google Scholar
• Blood pressure, cholesterol, and stroke in eastern Asia. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Lancet352(9143), 1801–1807 (1998).
   PubMed Web of Science ®Google Scholar
• Hachinski V, Graffagnino C, Beaudry M et al. Lipids and stroke: a paradox resolved. Arch. Neurol.53(4), 303–308 (1996).
   PubMedGoogle Scholar
• Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet360(9326), 7–22 (2002).
   PubMed Web of Science ®Google Scholar
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet344(8934), 1383–1389 (1994).
   PubMed Web of Science ®Google Scholar
• Sacks FM, Pfeffer MA, Moye LA et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N. Engl. J. Med.335(14), 1001–1009 (1996).
   PubMed Web of Science ®Google Scholar
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels: the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N. Engl. J. Med.339(19), 1349–1357 (1998).
   PubMed Web of Science ®Google Scholar
• Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation97(15), 1440–1445 (1998).
   PubMed Web of Science ®Google Scholar
• Byington RP, Davis BR, Plehn JF et al. Reduction of stroke events with pravastatin: the prospective pravastatin pooling (PPP) project. Circulation103(3), 387–392 (2001).
   PubMed Web of Science ®Google Scholar
• Collins R, Armitage J, Parish S, Sleight P, Peto R. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet363(9411), 757–767 (2004).
   PubMed Web of Science ®Google Scholar
• Shepherd J, Cobbe SM, Ford I et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N. Engl. J. Med.333(20), 1301–1307 (1995).
   PubMed Web of Science ®Google Scholar
• Shepherd J, Blauw GJ, Murphy MB et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet360(9346), 1623–1630 (2002).
   PubMed Web of Science ®Google Scholar
• Sever PS, Dahlof B, Poulter NR et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian cardiac outcomes trial – lipid lowering arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet361(9364), 1149–1158 (2003).
   PubMed Web of Science ®Google Scholar
• Jonsson N, Asplund K. Does pretreatment with statins improve clinical outcome after stroke? A pilot case-referent study. Stroke32(5), 1112–1115 (2001).
   PubMed Web of Science ®Google Scholar
• Thomas M, Mann J. Increased thrombotic vascular events after change of statin. Lancet352(9143), 1830–1831 (1998).
   PubMed Web of Science ®Google Scholar
• Heeschen C, Hamm CW, Laufs U et al. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation105(12), 1446–1452 (2002).
   PubMed Web of Science ®Google Scholar
• Amarenco P, Bogousslavsky J, Callahan A, 3rd et al. High-dose atorvastatin after stroke or transient ischemic attack. N. Engl. J. Med.355(6), 549–559 (2006).
   PubMed Web of Science ®Google Scholar
• Goldstein LB, Amarenco P, Szarek M et al. Hemorrhagic stroke in the stroke prevention by aggressive reduction in cholesterol levels study. Neurology70(24 Pt 2), 2364–2370 (2008).
   PubMed Web of Science ®Google Scholar
• Vergouwen MD, de Haan RJ, Vermeulen M, Roos YB. Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke39(2), 497–502 (2008).
   PubMed Web of Science ®Google Scholar
• Bang OY, Saver JL, Liebeskind DS et al. Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis. Neurology68(10), 737–742 (2007).
   PubMed Web of Science ®Google Scholar
• Mascitelli L, Pezzetta F. Low LDL cholesterol, statins, and brain hemorrhage: should we worry? Neurology69(10), 1061–1062 (2007).
   PubMedGoogle Scholar
• Kim HH, Sawada N, Soydan G et al. Additive effects of statin and dipyridamole on cerebral blood flow and stroke protection. J. Cereb. Blood Flow Metab.28(7), 1285–1293 (2008).
   PubMedGoogle Scholar
• Nishimura Y, Ito T, Saavedra JM. Angiotensin II AT (1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke31(10), 2478–2486 (2000).
   PubMed Web of Science ®Google Scholar
• Saavedra JM, Benicky J, Zhou J. Mechanisms of the anti-ischemic effect of angiotensin II AT (1) receptor antagonists in the brain. Cell Mol. Neurobiol.26(7–8), 1099–1111 (2006).
   PubMed Web of Science ®Google Scholar
• Culman J, Zhao Y, Gohlke P, Herdegen T. PPAR-γ: therapeutic target for ischemic stroke. Trends Pharmacol. Sci.28(5), 244–249 (2007).
   PubMed Web of Science ®Google Scholar
• Chu K, Lee ST, Koo JS et al. Peroxisome proliferator-activated receptor-γ-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia. Brain Res.1093(1), 208–218 (2006).
   PubMed Web of Science ®Google Scholar
• Tsai SK, Hung LM, Fu YT et al. Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats. J. Vasc. Surg.46(2), 346–353 (2007).
   PubMed Web of Science ®Google Scholar
• Endres M, Gertz K, Lindauer U et al. Mechanisms of stroke protection by physical activity. Ann. Neurol.54(5), 582–590 (2003).
   PubMed Web of Science ®Google Scholar
• Sasaki Y, Noguchi T, Yamamoto E et al. Effects of voluntary exercise on cerebral thrombosis and endothelial function in spontaneously hypertensive rats (SHRSP/Izm). Clin. Exp. Pharmacol. Physiol.31(Suppl. 2), S47–S48 (2004).
   PubMedGoogle Scholar
• Laufs U, Werner N, Link A et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation109(2), 220–226 (2004).
   PubMed Web of Science ®Google Scholar
• Gertz K, Priller J, Kronenberg G et al. Physical activity improves long-term stroke outcome via endothelial nitric oxide synthase-dependent augmentation of neovascularization and cerebral blood flow. Circ. Res.99(10), 1132–1140 (2006).
   PubMed Web of Science ®Google Scholar
• Hafezi-Moghadam A, Simoncini T, Yang Z et al. Acute cardiovascular protective effects of corticosteroids are mediated by nontranscriptional activation of endothelial nitric oxide synthase. Nat. Med.8(5), 473–479 (2002).
   PubMed Web of Science ®Google Scholar
• Limbourg FP, Huang Z, Plumier JC et al. Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J. Clin. Invest.110(11), 1729–1738 (2002).
   PubMed Web of Science ®Google Scholar
• Simoncini T, Hafezi-Moghadam A, Brazil DP et al. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature407(6803), 538–541 (2000).
   PubMed Web of Science ®Google Scholar
• Hiroi Y, Kim HH, Ying H et al. Rapid nongenomic actions of thyroid hormone. Proc. Natl Acad. Sci. USA103(38), 14104–14109 (2006).
   PubMed Web of Science ®Google Scholar
• Murohara T, Asahara T, Silver M et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest.101(11), 2567–2578 (1998).
   PubMed Web of Science ®Google Scholar
• Aicher A, Heeschen C, Mildner-Rihm C et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med.9(11), 1370–1376 (2003).
   PubMed Web of Science ®Google Scholar
• Ovbiagele B, Saver JL, Starkman S et al. Statin enhancement of collateralization in acute stroke. Neurology68(24), 2129–2131 (2007).
   PubMed Web of Science ®Google Scholar
• Chen J, Zacharek A, Zhang C et al. Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice. J. Neurosci.25(9), 2366–2375 (2005).
   PubMed Web of Science ®Google Scholar
• Lee CD, Folsom AR, Blair SN. Physical activity and stroke risk: a meta-analysis. Stroke34(10), 2475–2481 (2003).
   PubMed Web of Science ®Google Scholar
• Di Castelnuovo A, Rotondo S, Iacoviello L, Donati MB, De Gaetano G. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation105(24), 2836–2844 (2002).
   PubMed Web of Science ®Google Scholar
• Thomas D, Bath PM, Lees K et al. Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122). Int. J. Stroke1(4), 245–249 (2006).
   PubMedGoogle Scholar
• Hassan A, Gormley K, O’Sullivan M et al. Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease. Stroke35(3), 654–659 (2004).
   PubMed Web of Science ®Google Scholar
• Wang XL, Wang J. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol. Genet. Metab.70(4), 241–251 (2000).
   PubMed Web of Science ®Google Scholar
• Starke RM, Kim GH, Komotar RJ et al. Endothelial nitric oxide synthase gene single-nucleotide polymorphism predicts cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J. Cereb. Blood Flow Metab.28(6), 1204–1211 (2008).
   PubMed Web of Science ®Google Scholar
• Ko NU, Rajendran P, Kim H et al. Endothelial nitric oxide synthase polymorphism (-786T – C) and increased risk of angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Stroke39(4), 1103–1108 (2008).
   PubMed Web of Science ®Google Scholar
• McGirt MJ, Lynch JR, Parra A et al. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke33(12), 2950–2956 (2002).
   PubMed Web of Science ®Google Scholar
• White BC, Sullivan JM, DeGracia DJ et al. Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J. Neurol. Sci.179(S 1–2), 1–33 (2000).
   PubMed Web of Science ®Google Scholar
• Lok J, Gupta P, Guo S et al. Cell–cell signaling in the neurovascular unit. Neurochem. Res.32(12), 2032–2045 (2007).
   PubMed Web of Science ®Google Scholar
• Abbott NJ, Ronnback L, Hansson E. Astrocyte–endothelial interactions at the blood–brain barrier. Nat. Rev. Neurosci.7(1), 41–53 (2006).
   PubMed Web of Science ®Google Scholar
• Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci.4(5), 399–415 (2003).
   PubMed Web of Science ®Google Scholar
• Wu D. Neuroprotection in experimental stroke with targeted neurotrophins. NeuroRx2(1), 120–128 (2005).
   PubMedGoogle Scholar
• Lindsay RM. Neuron saving schemes. Nature373(6512), 289–290 (1995).
   PubMed Web of Science ®Google Scholar
• Kitagawa H, Hayashi T, Mitsumoto Y et al. Reduction of ischemic brain injury by topical application of glial cell line-derived neurotrophic factor after permanent middle cerebral artery occlusion in rats. Stroke29(7), 1417–1422 (1998).
   PubMed Web of Science ®Google Scholar
• Tomac A, Lindqvist E, Lin LF et al. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature373(6512), 335–339 (1995).
   PubMed Web of Science ®Google Scholar
• Harvey BK, Hoffer BJ, Wang Y. Stroke and TGF-β proteins: glial cell line-derived neurotrophic factor and bone morphogenetic protein. Pharmacol. Ther.105(2), 113–125 (2005).
   PubMed Web of Science ®Google Scholar
• Lang AE, Gill S, Patel NK et al. Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann. Neurol.59(3), 459–466 (2006).
   PubMed Web of Science ®Google Scholar
• Patel NK, Bunnage M, Plaha P et al. Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study. Ann. Neurol.57(2), 298–302 (2005).
   PubMed Web of Science ®Google Scholar
• Leventhal C, Rafii S, Rafii D, Shahar A, Goldman SA. Endothelial trophic support of neuronal production and recruitment from the adult mammalian subependyma. Mol. Cell Neurosci.13(6), 450–464 (1999).
   PubMed Web of Science ®Google Scholar
• Chen J, Zhang C, Jiang H et al. Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. J. Cereb. Blood Flow Metab.25(2), 281–290 (2005).
   PubMed Web of Science ®Google Scholar
• Shen Q, Goderie SK, Jin L et al. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science304(5675), 1338–1340 (2004).
   PubMed Web of Science ®Google Scholar
• del Zoppo GJ, Mabuchi T. Cerebral microvessel responses to focal ischemia. J. Cereb. Blood Flow Metab.23(8), 879–894 (2003).
   PubMed Web of Science ®Google Scholar
• Cunningham LA, Wetzel M, Rosenberg GA. Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia50(4), 329–339 (2005).
   PubMed Web of Science ®Google Scholar
• Lipton P. Ischemic cell death in brain neurons. Physiol. Rev.79(4), 1431–1568 (1999).
   PubMed Web of Science ®Google Scholar
• Jiang X, Namura S, Nagata I. Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice. Neurosci. Lett.305(1), 41–44 (2001).
   PubMed Web of Science ®Google Scholar
• Heasman SJ, Ridley AJ. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat. Rev. Mol. Cell Biol.9(9), 690–701 (2008).
   PubMed Web of Science ®Google Scholar
• Sawada N, Salomone S, Kim HH, Kwiatkowski DJ, Liao JK. Regulation of endothelial nitric oxide synthase and postnatal angiogenesis by Rac1. Circ. Res.103(4), 360–368 (2008).
   PubMed Web of Science ®Google Scholar
• Tan W, Palmby TR, Gavard J et al. An essential role for Rac1 in endothelial cell function and vascular development. FASEB J.22(6), 1829–1838 (2008).
   PubMed Web of Science ®Google Scholar
• Sawada N, Kim HH, Moskowitz MA, Liao JK. Rac1 is a critical mediator of endothelium-derived neurotrophic activity. Sci. Signal2(61), ra10 (2009).
   PubMedGoogle Scholar
• Bierl C, Voetsch B, Jin RC, Handy DE, Loscalzo J. Determinants of human plasma glutathione peroxidase (GPx-3) expression. J. Biol. Chem.279(26), 26839–26845 (2004).
   PubMed Web of Science ®Google Scholar
• Voetsch B, Jin RC, Bierl C et al. Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene: a novel risk factor for arterial ischemic stroke among young adults and children. Stroke38(1), 41–49 (2007).
   PubMed Web of Science ®Google Scholar
• Gabai VL, Sherman MY. Invited review: Interplay between molecular chaperones and signaling pathways in survival of heat shock. J. Appl. Physiol.92(4), 1743–1748 (2002).
   PubMed Web of Science ®Google Scholar
• Kamradt MC, Chen F, Sam S, Cryns VL. The small heat shock protein α B-crystallin negatively regulates apoptosis during myogenic differentiation by inhibiting caspase-3 activation. J. Biol. Chem.277(41), 38731–38736 (2002).
   PubMedGoogle Scholar
• Beere HM. Stressed to death: regulation of apoptotic signaling pathways by the heat shock proteins. Sci. STKE2001(93), RE1 (2001).
   PubMedGoogle Scholar
• Bornstein P, Agah A, Kyriakides TR. The role of thrombospondins 1 and 2 in the regulation of cell–matrix interactions, collagen fibril formation, and the response to injury. Int. J. Biochem. Cell Biol.36(6), 1115–1125 (2004).
   PubMed Web of Science ®Google Scholar
• Bornstein P. Thrombospondins as matricellular modulators of cell function. J. Clin. Invest.107(8), 929–934 (2001).
   PubMed Web of Science ®Google Scholar
• Baloh RH, Tansey MG, Lampe PA et al. Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRα3–RET receptor complex. Neuron21(6), 1291–1302 (1998).
   PubMed Web of Science ®Google Scholar
• Reuss B, von Bohlen und Halbach O. Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res.313(2), 139–157 (2003).
   PubMed Web of Science ®Google Scholar
• Junier MP. What role (s) for TGFα in the central nervous system? Prog Neurobiol, 62(5), 443–473 (2000).
   PubMed Web of Science ®Google Scholar
• Wang Y, Chang CF, Morales M, Chiang YH, Hoffer J. Protective effects of glial cell line-derived neurotrophic factor in ischemic brain injury. Ann. NY Acad. Sci.962, 423–437 (2002).
   PubMed Web of Science ®Google Scholar
• Honma Y, Araki T, Gianino S et al. Artemin is a vascular-derived neurotropic factor for developing sympathetic neurons. Neuron35(2), 267–282 (2002).
   PubMedGoogle Scholar
• Damon DH, Teriele JA, Marko SB. Vascular-derived artemin: a determinant of vascular sympathetic innervation? Am. J. Physiol. Heart Circ. Physiol.293(1), H266–H273 (2007).
   PubMed Web of Science ®Google Scholar
• Bespalov MM, Saarma M. GDNF family receptor complexes are emerging drug targets. Trends Pharmacol. Sci.28(2), 68–74 (2007).
   PubMed Web of Science ®Google Scholar
• Baloh RH, Gorodinsky A, Golden JP et al. GFRα3 is an orphan member of the GDNF/neurturin/persephin receptor family. Proc. Natl Acad. Sci. USA95(10), 5801–5806 (1998).
   PubMedGoogle Scholar
• Rosenblad C, Gronborg M, Hansen C et al.In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin. Mol. Cell Neurosci.15(2), 199–214 (2000).
   PubMedGoogle Scholar
• Ducray A, Krebs SH, Schaller B et al. GDNF family ligands display distinct action profiles on cultured GABAergic and serotonergic neurons of rat ventral mesencephalon. Brain Res.1069(1), 104–112 (2006).
   PubMed Web of Science ®Google Scholar
• Bonde C, Kristensen BW, Blaabjerg M et al. GDNF and neublastin protect against NMDA-induced excitotoxicity in hippocampal slice cultures. Neuroreport11(18), 4069–4073 (2000).
   PubMedGoogle Scholar
• Sakai T, Johnson KJ, Murozono M et al. Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis. Nat. Med.7(3), 324–330 (2001).
   PubMed Web of Science ®Google Scholar
• Reuss B, Dono R, Unsicker K. Functions of fibroblast growth factor (FGF)-2 and FGF-5 in astroglial differentiation and blood–brain barrier permeability: evidence from mouse mutants. J. Neurosci.23(16), 6404–6412 (2003).
   PubMed Web of Science ®Google Scholar
• Unsicker K, Krieglstein K. Co-activation of TGF-β and cytokine signaling pathways are required for neurotrophic functions. Cytokine Growth Factor Rev.11(1–2), 97–102 (2000).
   PubMedGoogle Scholar
• Palmer TD, Willhoite AR, Gage FH. Vascular niche for adult hippocampal neurogenesis. J. Comp. Neurol.425(4), 479–494 (2000).
   PubMed Web of Science ®Google Scholar
• Kumar P, Wu H, McBride JL et al. Transvascular delivery of small interfering RNA to the central nervous system. Nature448(7149), 39–43 (2007).
   PubMed Web of Science ®Google Scholar
• Spencer BJ, Verma IM. Targeted delivery of proteins across the blood–brain barrier. Proc. Natl Acad. Sci. USA104(18), 7594–7599 (2007).
   PubMed Web of Science ®Google Scholar
• Guo S, Kim WJ, Lok J et al. Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons. Proc. Natl Acad. Sci. USA105(21), 7582–7587 (2008).
   PubMed Web of Science ®Google Scholar
• Kennedy J, Hill MD, Ryckborst KJ et al. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol.6(11), 961–969 (2007).
   PubMed Web of Science ®Google Scholar
• Bogousslavsky J, Victor SJ, Salinas EO et al. Fiblast (trafermin) in acute stroke: results of the European–Australian Phase II/III safety and efficacy trial. Cerebrovasc. Dis.14(3–4), 239–251 (2002).
   PubMed Web of Science ®Google Scholar
• Fisher M, Meadows ME, Do T et al. Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab.15(6), 953–959 (1995).
   PubMed Web of Science ®Google Scholar
• Cleaver O, Melton DA. Endothelial signaling during development. Nat. Med.9(6), 661–668 (2003).
   PubMed Web of Science ®Google Scholar
• Gao Y, Dickerson JB, Guo F, Zheng J, Zheng Y. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc. Natl Acad. Sci. USA101(20), 7618–7623 (2004).
   PubMed Web of Science ®Google Scholar
• Tsukahara T, Yonekawa Y, Tanaka K et al. The role of brain-derived neurotrophic factor in transient forebrain ischemia in the rat brain. Neurosurgery34(2), 323–331 (1994).
   PubMed Web of Science ®Google Scholar
• Prehn JH, Backhauss C, Krieglstein J. Transforming growth factor-β1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischemic injury in vivo. J. Cereb. Blood Flow Metab.13(3), 521–525 (1993).
   PubMed Web of Science ®Google Scholar
• Wang Y, Chang CF, Morales M et al. Bone morphogenetic protein-6 reduces ischemia-induced brain damage in rats. Stroke32(9), 2170–2178 (2001).
   PubMedGoogle Scholar
• Liu Y, Belayev L, Zhao W et al. The effect of bone morphogenetic protein-7 (BMP-7) on functional recovery, local cerebral glucose utilization and blood flow after transient focal cerebral ischemia in rats. Brain Res.905(1–2), 81–90 (2001).
   PubMedGoogle Scholar
• Yao DL, Masonic K, Petullo D et al. Pretreatment with intravenous FGF-13 reduces infarct volume and ameliorates neurological deficits following focal cerebral ischemia in rats. Brain Res.818(1), 140–146 (1999).
   PubMed Web of Science ®Google Scholar
• Ellsworth JL, Garcia R, Yu J, Kindy MS. Fibroblast growth factor-18 reduced infarct volumes and behavioral deficits after transient occlusion of the middle cerebral artery in rats. Stroke34(6), 1507–1512 (2003).
   PubMed Web of Science ®Google Scholar
• Justicia C, Perez-Asensio FJ, Burguete MC, Salom JB, Planas AM. Administration of transforming growth factor-α reduces infarct volume after transient focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab.21(9), 1097–1104 (2001).
   PubMedGoogle Scholar